Tenet Healthcare (NYSE:THC) EVP Lisa Foo Sells 8,000 Shares

Tenet Healthcare Corporation (NYSE:THC) EVP Lisa Foo sold 8,000 shares of the firm’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total transaction of $1,436,240.00. Following the completion of the sale, the executive vice president owned 20,878 shares of the company’s stock, valued at $3,748,227.34. The trade was a 27.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Tenet Healthcare Trading Up 1.2%

NYSE:THC opened at $179.57 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.39. The stock has a market capitalization of $15.87 billion, a price-to-earnings ratio of 11.50, a PEG ratio of 0.76 and a beta of 1.52. The firm has a fifty day simple moving average of $168.67 and a two-hundred day simple moving average of $149.61. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $185.25.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 EPS for the quarter, topping analysts’ consensus estimates of $2.84 by $1.18. The business had revenue of $5.27 billion during the quarter, compared to analysts’ expectations of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The business’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period last year, the company posted $2.31 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. Analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Bank of America lifted their price objective on shares of Tenet Healthcare from $165.00 to $180.00 and gave the company a “buy” rating in a report on Wednesday, May 14th. Wells Fargo & Company lifted their price objective on shares of Tenet Healthcare from $195.00 to $200.00 and gave the company an “overweight” rating in a report on Thursday, August 14th. Mizuho lifted their price objective on shares of Tenet Healthcare from $184.00 to $194.00 and gave the company an “outperform” rating in a report on Friday, July 11th. Stephens upgraded shares of Tenet Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Finally, Robert W. Baird reduced their price objective on shares of Tenet Healthcare from $195.00 to $167.00 and set a “neutral” rating for the company in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $191.88.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD lifted its position in shares of Tenet Healthcare by 6.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 7,596,544 shares of the company’s stock valued at $1,021,736,000 after purchasing an additional 463,552 shares in the last quarter. Boston Partners lifted its position in shares of Tenet Healthcare by 95.0% during the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. Ameriprise Financial Inc. raised its position in Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock worth $373,020,000 after acquiring an additional 157,109 shares during the period. Dimensional Fund Advisors LP raised its position in Tenet Healthcare by 12.2% in the first quarter. Dimensional Fund Advisors LP now owns 1,675,199 shares of the company’s stock worth $225,297,000 after acquiring an additional 181,667 shares during the period. Finally, Nuveen LLC bought a new stake in Tenet Healthcare in the first quarter worth about $218,549,000. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.